John Harry Sweigard

Title: John Harry Sweigard: Innovator in Complement Disorders

Introduction

John Harry Sweigard is a notable inventor based in Dorchester, MA (US). He has made significant contributions to the field of medical research, particularly in the area of complement disorders. His innovative work has led to the development of methods and kits that aim to diagnose and treat these complex conditions.

Latest Patents

John Harry Sweigard holds a patent for "Compositions, methods and kits for modeling, diagnosing, and treating complement disorders." This patent includes systems, compositions, methods, and kits designed to identify potential therapeutic agents for the treatment of complement-based ocular diseases. The methods and kits utilize a complement component 3 (C3) protein or derivative that interacts with ocular cells or tissue. Additionally, his invention provides for the diagnosis and prognosis of complement-associated ocular diseases. The patent also encompasses compositions and methods for regulating or treating complement-related conditions using proteins such as CD46, CD55, and a recombinant chimeric soluble terminator of activated complement (STAC) protein.

Career Highlights

John Harry Sweigard is affiliated with Tufts University, where he continues to advance his research in complement disorders. His work is characterized by a commitment to improving diagnostic and therapeutic strategies in this specialized field.

Collaborations

He has collaborated with esteemed colleagues, including Rajendra Kumar-Singh and Siobhan M Cashman, to further enhance the impact of his research.

Conclusion

John Harry Sweigard's contributions to the field of complement disorders exemplify the importance of innovation in medical research. His patented methods and compositions hold promise for improving the diagnosis and treatment of ocular diseases related to complement dysfunction.